Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC
There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected Non Small Cell Lung Cancer|
|Study Start Date:||February 2006|
|Study Completion Date:||April 2007|
|Primary Completion Date:||April 2007 (Final data collection date for primary outcome measure)|
We propose to retrospectively examine the Washington University School of Medicine experience on all patients receiving adjuvant chemotherapy between 2003 and 2005. We will retrospectively analyze the survival and outcomes in the lung cancer patients receiving adjuvant chemotherapy following surgical resection.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00484016
|Principal Investigator:||Ramaswamy Govindan, M.D.||Washington University School of Medicine|